Clonidine and Other Sympatholytics
Clonidine and Other Sympatholytics is a topic covered in the Washington Manual of Medical Therapeutics.
To view the entire topic, please log in or purchase a subscription.
The Washington Manual is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
General Principles
- Clonidine belongs to the imidazoline class; these medications are also referred to as sympatholytics.
- Other commonly encountered members of this class include guanfacine, dexmedetomidine, tizanidine, and the topical nasal and ocular imidazolines (tetrahydrozoline, oxymetazoline, naphazoline, and brimonidine).
Pathophysiology
- Sympatholytics are centrally acting alpha-2 adrenergic agonists; they have a negative feedback effect on catecholamine release and thus decrease heart rate, blood pressure, and CNS excitation.
- Sympatholytics also interact with the less-understood imidazoline (I) receptor system; this system also has CNS depressant and antihypertensive actions.
- When used as intended, the topical nasal and ocular imidazolines act primarily as alpha-1 adrenergic agonists, and thus induce local vasoconstriction.
- In large overdose or when consumed by mouth, these agents act primarily as alpha-2 adrenergic agonists.
- Early in the course of sympatholytic poisoning, off-target effects on alpha-1 adrenoceptors may lead to peripheral vasoconstriction and transient hypertension.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
General Principles
- Clonidine belongs to the imidazoline class; these medications are also referred to as sympatholytics.
- Other commonly encountered members of this class include guanfacine, dexmedetomidine, tizanidine, and the topical nasal and ocular imidazolines (tetrahydrozoline, oxymetazoline, naphazoline, and brimonidine).
Pathophysiology
- Sympatholytics are centrally acting alpha-2 adrenergic agonists; they have a negative feedback effect on catecholamine release and thus decrease heart rate, blood pressure, and CNS excitation.
- Sympatholytics also interact with the less-understood imidazoline (I) receptor system; this system also has CNS depressant and antihypertensive actions.
- When used as intended, the topical nasal and ocular imidazolines act primarily as alpha-1 adrenergic agonists, and thus induce local vasoconstriction.
- In large overdose or when consumed by mouth, these agents act primarily as alpha-2 adrenergic agonists.
- Early in the course of sympatholytic poisoning, off-target effects on alpha-1 adrenoceptors may lead to peripheral vasoconstriction and transient hypertension.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Bhat, Pavat, et al., editors. "Clonidine and Other Sympatholytics." Washington Manual of Medical Therapeutics, 35th ed., Wolters Kluwer Health, 2016. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602873/all/Clonidine_and_Other_Sympatholytics.
Clonidine and Other Sympatholytics. In: Bhat PP, Dretler AA, Gdowski MM, et al, eds. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602873/all/Clonidine_and_Other_Sympatholytics. Accessed April 2, 2023.
Clonidine and Other Sympatholytics. (2016). In Bhat, P., Dretler, A., Gdowski, M., Ramgopal, R., & Williams, D. (Eds.), Washington Manual of Medical Therapeutics (35th ed.). Wolters Kluwer Health. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602873/all/Clonidine_and_Other_Sympatholytics
Clonidine and Other Sympatholytics [Internet]. In: Bhat PP, Dretler AA, Gdowski MM, Ramgopal RR, Williams DD, editors. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. [cited 2023 April 02]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602873/all/Clonidine_and_Other_Sympatholytics.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Clonidine and Other Sympatholytics
ID - 602873
ED - Williams,Dominique,
ED - Bhat,Pavat,
ED - Dretler,Alexandra,
ED - Gdowski,Mark,
ED - Ramgopal,Rajeev,
BT - Washington Manual of Medical Therapeutics
UR - https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602873/all/Clonidine_and_Other_Sympatholytics
PB - Wolters Kluwer Health
ET - 35
DB - The Washington Manual
DP - Unbound Medicine
ER -